Association of β-Blocker Exposure With Outcomes in Heart Failure Differs Between African American and White Patients

Abstract excerpt

BACKGROUND: β-Blockers (BB) are a mainstay of heart failure (HF) treatment, yet there are inconclusive data regarding their efficacy in African American individuals. METHODS AND RESULTS: We performed a retrospective study of insured patients who received care from a large health system who were hospitalized for HF between January 2000 and June 2008 and had a documented ejection fraction <50%. BB exposure was...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Heart Failure Treatment and Management